IMPOWER110: INTERIM OVERALL SURVIVAL (OS) ANALYSIS OF A PHASE III STUDY OF ATEZOLIZUMAB (ATEZO) MONOTHERAPY VS PLATINUM-BASED CHEMOTHERAPY (CHEMO) AS FIRST-LINE (1L) TREATMENT IN PD-L1-SELECTED NSCLC

Herbst R., De Marinis F., Giaccone G., Reinmuth N., Vergnenegre A., Barrios C., ...Daha Fazla

JOURNAL FOR IMMUNOTHERAPY OF CANCER, cilt.8, 2020 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Cilt numarası: 8
• Basım Tarihi: 2020
• Doi Numarası: 10.1136/lba2019.1
• Dergi Adı: JOURNAL FOR IMMUNOTHERAPY OF CANCER
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE, Directory of Open Access Journals
• İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır